Journal News

Iron could be key to treating a global parasitic disease

Ankita Arora
April 16, 2024

Iron is a necessary nutrient to maintain bodily functions and healthy red blood cells. But the benefits of iron may extend further.

In a recent study published in the Journal of Biological Chemistry, researchers Sourav Banerjee and Rupak Datta showed that iron supplement can control symptoms of a global pathogenic disease, leishmaniasis, caused by the parasite Leishmania.  

This illustration shows a cutaneous leishmaniasis ulcer and a close-up view of Leishmania amastigote–infected human histiocyte cells.
This illustration shows a cutaneous leishmaniasis ulcer and a close-up view of Leishmania amastigote–infected human histiocyte cells.

Leishmaniasis, found in tropical and subtropical countries, is spread by the bite of an infected female sandfly. Between 600 million and 1 billion people are at risk of infection, with an estimate of up to 1 million new cases occurring annually. It is among the top 10 neglected tropical diseases, mainly affecting people in poverty, and is connected to malnutrition, poor housing and a weakened immune system. 

Depending on the Leishmania species causing the infection, symptoms and host immune response might vary — so understanding leishmaniasis is a complex problem. The high cost and toxicity of the drugs and the emergence of drug resistance in parasites limit the efficacy of current treatments.

Banerjee was a graduate student in Datta’s laboratory at the Indian Institute of Science Education and Research Kolkata during the study and is now a research associate at the University of Cambridge.

“While live-attenuated and adenovirus-based vaccines are currently under development, we are still far away from an end, as we do not know how efficiently these vaccine candidates would generate memory immune response,” Banerjee said. “Therefore, to better treat this disease, we need to have an in-depth knowledge of the pathogenesis of different types of leishmaniasis caused by the different Leishmania species.”

The study focused on the speciesLeishmania major, which typically replicates at the site of infection and causes cutaneous leishmaniasis, or CL. This common form of the disease causes skin ulceration and long-lasting scars.

Researchers know that Leishmania parasites need to hijack iron stores from the host to replicate and cause infection.  However, they know little about how the infection changes our strict iron regulatory system. What are the consequences both at the site of infection and systemically?

To answer these questions, Banerjee and Datta infected mice with L. major in their footpads. With time, a lesion developed at the site of infection and showed increased iron accumulation. Further, the infection caused widespread changes in iron balance. It decreased hemoglobin levels, increased iron in the blood and caused spleen enlargement.

“We found that Leishmania major infection eventually leads to tissue damage and a significant depletion in liver iron reserves,” Banerjee said. “It is of great importance to know that  in addition to causing a localized skin ulceration, Leishmania major infection has a far-reaching effect on internal organs and collectively can lead to anemic condition.”

To determine whether iron supplements can restore the depleted iron reserves and potentially restrict parasite infection, the researchers treated L. major-infected mice with oral iron. The parasite load decreased compared to untreated controls, and the iron supplement restored iron levels in the liver and serum.

“We show that oral iron supplementation at a minimal dose is highly effective in preventing the parasite infection in the experimental mouse model,” Banerjee said. “This highlights that nutritional immunity can play an essential role in battling Leishmania infection. This could be a cost-effective treatment regimen that is devoid of any painful interventions.”

Banerjee hopes parasitologists will continue investigating the molecular mechanisms behind the iron homeostasis perturbation upon L. major infection to determine whether the iron imbalance is mediated by the parasite or the host immune responses.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Ankita Arora

Ankita Arora is an RNA-biologist-turned-freelance-science-writer. Her 12 years of experience in research and her storytelling skills help her distill science jargon into bite-size chunks that are fun to read. She aims to make science enjoyable and accessible for all.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The quest to treat and cure xerostomia
Interview

The quest to treat and cure xerostomia

July 23, 2024

Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.

There's more to blue cheese than just the stench
News

There's more to blue cheese than just the stench

July 21, 2024

Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.